*From Meryl Nass:*

*Dr. Thomas Cowan believes that no viruses exist.  Dr. Andrew Kaufman is
> science-light. Those are Mr. Rappoport’s guiding lights.*
>
>
> *Why did that CDC document written in February say CDC had no quantifiable
> virus samples available?  Because CDC was scamming the US citizenry by
> creating a faulty test for Covid (and they were quickly informed that it
> was faulty, but they did not fix it) and refusing to allow anyone else to
> offer a valid test, until Feb 29.  Of course they had the virus.  But they
> were not sharing their information nor any samples with anyone until
> forced, on Feb 29.  I suspect this was part of a plan to allow the virus to
> spread through the US in the absence of a means to detect it with tests.
> But perhaps it was simply gross incompetence and hubris.*
>
> *You can call SARS-2 anything you want, but it acts like a virus.  But it
> is transmitted between people and some animals, whether you choose to
> believe it is alive or dead.  It is grown in labs. It is transmitted
> between animals in labs.   It can be destroyed (I call it killed) in a
> broth, petri dish, test tube with a number of drugs.  And its relatives
> were experimented on in labs, after the progenitors were taken from bats.
> And you have to grow them (viruses or whatever you call them) in labs in
> order to experiment on them.*
>
> *SARS-2 grows in cells in the back of the nose and throat at first, then
> moves into more cell types and can kill you by initiating cell death,
> cytokine storm, hyoercoagulability.*
>
> *No poisons do that.  It can only happen if the virus GROWS and
> MULTIPLIES.*
>
> *Here are some references, and I have included the beginning of the 3’d
> reference so you can see for yourselves if this is a virus, has been
> isolated, cultured, etc.*
>
>  Akst J. Australian Lab Cultures New Coronavirus as Infections Climb. The
> Scientist.
> https://www.the-scientist.com/news-opinion/australian-lab-cultures-new-coronavirus-as-infections-climb-67031
> .
>
> 2.  CDC has grown the COVID-19 virus in cell culture
> <https://www.cdc.gov/coronavirus/2019-ncov/about/grows-virus-cell-culture.html>,
> which is necessary for further studies, including for additional genetic
> characterization. The cell-grown virus was sent to NIH’s BEI
> ResourcesRepository
> <https://www.niaid.nih.gov/research/bei-resources-repository> for use by
> the broad scientific community.
>
> https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543926/
>
> Pathology <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543926/#>. 2020
> Oct 8
> doi: 10.1016/j.pathol.2020.09.012
> <https://dx.doi.org/10.1016%2Fj.pathol.2020.09.012> [Epub ahead of print]
> PMCID: PMC7543926
> Virus isolation of severe acute respiratory syndrome coronavirus 2
> (SARS-CoV-2) for diagnostic and research purposes
> Sacha Stelzer-Braid
> <https://www.ncbi.nlm.nih.gov/pubmed/?term=Stelzer-Braid%20S%5BAuthor%5D>,
> 1,2,∗ Gregory J. Walker
> <https://www.ncbi.nlm.nih.gov/pubmed/?term=Walker%20GJ%5BAuthor%5D>,1,2 
> Anupriya
> Aggarwal
> <https://www.ncbi.nlm.nih.gov/pubmed/?term=Aggarwal%20A%5BAuthor%5D>,3 Sonia
> R. Isaacs
> <https://www.ncbi.nlm.nih.gov/pubmed/?term=Isaacs%20SR%5BAuthor%5D>,1,2 
> Malinna
> Yeang <https://www.ncbi.nlm.nih.gov/pubmed/?term=Yeang%20M%5BAuthor%5D>,1,
> 4 Zin Naing
> <https://www.ncbi.nlm.nih.gov/pubmed/?term=Naing%20Z%5BAuthor%5D>,4 Alberto
> Ospina Stella
> <https://www.ncbi.nlm.nih.gov/pubmed/?term=Stella%20AO%5BAuthor%5D>,3 Stuart
> G. Turville
> <https://www.ncbi.nlm.nih.gov/pubmed/?term=Turville%20SG%5BAuthor%5D>,3
>  and William D. Rawlinson
> <https://www.ncbi.nlm.nih.gov/pubmed/?term=Rawlinson%20WD%5BAuthor%5D>1,2,
> 4
> Author information
> <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543926/#> Article notes
> <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543926/#> Copyright and
> License information
> <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543926/#> Disclaimer
> <https://www.ncbi.nlm.nih.gov/pmc/about/disclaimer/>
> Go to: <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543926/#>
> Abstract
> Isolation of the new pandemic virus severe acute respiratory syndrome
> coronavirus 2 (SARS-CoV-2) is essential for diagnostic and research
> purposes including assessment of novel therapeutics. Several primary and
> continuous cell lines are currently used, and new organoid and engineered
> cell lines are being developed for improved investigation and understanding
> of the human immune response to this virus. Here we review the growth of
> SARS-CoV-2 in reference standard cell lines, engineered cell lines and new
> developments in this field.
> *Key words: *Severe acute respiratory syndrome coronavirus 2, SARS-CoV-2,
> virus culture, cell culture, respiratory virus
> Go to: <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543926/#>
> Introduction
> Virus culture has been regarded as the reference standard of diagnostics
> for decades, as it allows for identification and isolation of active,
> replicating virus.1
> <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543926/#bib1> However,
> more rapid and sensitive molecular techniques, typically nucleic acid
> amplification tests (NAAT), such as real-time polymerase chain reaction
> (PCR), are now the major routine diagnostic tests used in virology
> diagnostic laboratories. Particularly with a novel or emerging virus such
> as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there are
> certain circumstances where virus isolation for diagnostic and research
> purposes remains important, including:
>
>    - 1.
>    To test convalescent sera for neutralising potential, for example as
>    therapeutics for coronavirus disease 2019 (COVID-19) patients in intensive
>    care units.
>    - 2.
>    To determine whether infectious virus is present, particularly to
>    inform return to work for previously infectious individuals such as health
>    care workers; individuals with persistent PCR positive results on serial
>    follow-up samples for viral clearance purpose; or when to discontinue
>    transmission-based precautions for patients.2
>    <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543926/#bib2>
>    - 3.
>    As first line testing for SARS-CoV-2 inactivation efficacy of
>    potential preventative or therapeutic compounds.
>    - 4.
>    For use as positive controls in the evaluation of molecular assays.3
>    <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543926/#bib3>
>
> *The first culture of SARS-CoV-2 internationally was reported by Caly and
> colleagues in Melbourne, Australia on 28 January 2020 and the cultured
> virus was rapidly shared globally with other researchers*.4
> <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543926/#bib4> The World
> Health Organization declared the novel coronavirus a virus of Public Health
> Emergency of International Concern shortly afterwards on 30 January, and a
> pandemic on 11 March 2020.
> Initial studies of SARS-CoV-2 virus culture were performed using the
> monkey kidney cell lines Vero-CCL81 and Vero E6.4
> <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543926/#bib4> , 5
> <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543926/#bib5> However,
> various cell lines have been reported as able to sustain SARS-CoV-2 growth
> and offer a closer approximation to the human immune response. *We review
> here the growth of the virus in existing standard (monkey and human) and
> engineered cell lines. We discuss the utility of human cell lines in virus
> culture*, and the potential for using these in human immunological and
> other studies.
> Go to: <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543926/#>
> SARS-CoV-2 virus isolation
> The SARS-CoV-2 virus requires the angiotensin converting enzyme 2 (ACE2)
> receptor6 <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543926/#bib6> for
> entry into the host cell. This receptor is expressed in lung epithelial
> cells as well as endothelial cells lining the arteries, veins, capillaries,
> small intestine, testes, renal tissue and cardiovascular tissue.7
> <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543926/#bib7>, 8
> <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543926/#bib8>, 9
> <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543926/#bib9> Infection of
> the host cell also relies on priming of the SARS-CoV-2 spike protein by the
> transmembrane serine protease (TMPRSS).6
> <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543926/#bib6> The ACE2
> receptor is also used as the receptor for both SARS-CoV and the related
> human respiratory alphacoronavirus NL63.8
> <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543926/#bib8>
> Clinical samples being collected for SARS-Cov-2 nucleic acid amplification
> tests are upper respiratory tract samples, typically sampling both the
> nose/nasopharyngeal and throat (oropharyngeal) with (preferably) flocked
> swabs, as recommended by the Australian Public Health Laboratory Network10
> <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543926/#bib10> and World
> Health Organization.11
> <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543926/#bib11> Lower
> respiratory tract samples including sputum (if produced) and
> bronchoalveolar lavage are collected if the lower respiratory tract is
> suspected to be involved, although risk of virus aerosolisation is higher.
> 11 <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543926/#bib11> The
> virus is detectable by reverse transcription quantitative PCR (RT-qPCR) in
> the stool of ∼30% patients, and while this may not be infectious,
> SARS-CoV-2 in one stool sample from a Chinese patient who died from
> COVID-19 was reported to be culturable after second round passage.12
> <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543926/#bib12> The virus
> is not commonly detected in urine; only one of nine patients had a very low
> level of SARS-CoV-2 in urine detected by real-time PCR in a study by Peng
> and colleagues.13
> <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543926/#bib13>
>
>
>
>
>
> On Nov 1, 2020, at 5:42 PM, Mark Crispin Miller <
> [email protected]> wrote:
>
>
> https://blog.nomorefakenews.com/2020/10/26/the-missing-virus-answering-critics-objections/
>
>
>
---

Support News from Underground: https://bit.ly/NFUSupport

Visit News from Underground: https://markcrispinmiller.com

You received this email because you are subscribed to News from Underground. To 
unsubscribe from this email list, please go to: 
http://www.simplelists.com/confirm.php?u=pIdjNUgiG2h8yxbhC54SSy4SEskAoEMs

For archives, please go to: https://archives.simplelists.com/nfu

Reply via email to